EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.
作者信息
Lankester A C, Albert M H, Booth C, Gennery A R, Güngör T, Hönig M, Morris E C, Moshous D, Neven B, Schulz A, Slatter M, Veys P
机构信息
Willem-Alexander Children's Hospital, Pediatric Stem Cell Transplantation Program, Leiden University Medical Center, Leiden, The Netherlands.
Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany.
出版信息
Bone Marrow Transplant. 2021 Sep;56(9):2052-2062. doi: 10.1038/s41409-021-01378-8. Epub 2021 Jul 5.
Abstract
摘要
相似文献
1
EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.
Bone Marrow Transplant. 2021 Sep;56(9):2052-2062. doi: 10.1038/s41409-021-01378-8. Epub 2021 Jul 5.
2
Decision making on HSCT in patients with hemoglobinopathies; an EBMT Pediatric Diseases Working Party and Inborn Errors Working Party scenario-based survey on physicians' perspectives.
Bone Marrow Transplant. 2023 May;58(5):584-586. doi: 10.1038/s41409-023-01926-4. Epub 2023 Jan 26.
3
Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working Party.
Bone Marrow Transplant. 2023 May;58(5):594-596. doi: 10.1038/s41409-023-01918-4. Epub 2023 Feb 14.
4
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis.
Blood. 2022 Mar 31;139(13):2066-2079. doi: 10.1182/blood.2021014687.
5
The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders: A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT.
Front Pediatr. 2019 Oct 24;7:436. doi: 10.3389/fped.2019.00436. eCollection 2019.
6
Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.
Bone Marrow Transplant. 2018 Aug;53(8):1030-1037. doi: 10.1038/s41409-018-0137-1. Epub 2018 Mar 7.
7
Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity.
Eur J Pediatr. 2022 Nov;181(11):3889-3898. doi: 10.1007/s00431-022-04614-5. Epub 2022 Sep 14.
8
ATG or no ATG? - survey of clinical practice in EBMT centers on behalf of the Transplant Complications Working Party of EBMT.
Bone Marrow Transplant. 2023 Mar;58(3):337-339. doi: 10.1038/s41409-022-01889-y. Epub 2022 Dec 5.
9
The EBMT paediatric diseases working party and the first ESH-EBMT training course on blood and marrow transplantation in children. Introduction.
Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S1-2. doi: 10.1038/bmt.2008.44.
10
Hematopoietic stem cell transplantation for inborn errors of metabolism: A report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Pediatr Transplant. 2016 Mar;20(2):203-14. doi: 10.1111/petr.12672. Epub 2016 Jan 25.
引用本文的文献
1
First Report of Hematopoietic Stem Cell Transplantation for Children Diagnosed with Wiskott-Aldrich Syndrome in Vietnam.
J Blood Med. 2025 Aug 12;16:373-383. doi: 10.2147/JBM.S528827. eCollection 2025.
2
Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: an observational -prospective multi-center study of the Italian Primary Immune Deficiency Network (IPINET).
EClinicalMedicine. 2025 Jun 9;84:103271. doi: 10.1016/j.eclinm.2025.103271. eCollection 2025 Jun.
3
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study.
Blood Adv. 2025 Aug 26;9(16):4126-4135. doi: 10.1182/bloodadvances.2025016158.
4
A survey of diagnosis and therapy of inborn errors of immunity among practice-based physicians and clinic-based pneumologists and hemato-oncologists.
Front Immunol. 2025 Jun 5;16:1597635. doi: 10.3389/fimmu.2025.1597635. eCollection 2025.
5
Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis.
Bone Marrow Transplant. 2025 Apr 22. doi: 10.1038/s41409-025-02592-4.
6
Second Allogeneic Hematopoietic Cell Transplantation Following Graft Failure in Children.
J Korean Med Sci. 2025 Mar 17;40(10):e48. doi: 10.3346/jkms.2025.40.e48.
7
Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott-Aldrich syndrome: a case report.
Front Immunol. 2025 Feb 4;16:1495666. doi: 10.3389/fimmu.2025.1495666. eCollection 2025.
8
Relevance of Recent Thymic Emigrants Following Allogeneic Hematopoietic Cell Transplantation for Pediatric Patients with Inborn Errors of Immunity.
Transplant Cell Ther. 2025 Apr;31(4):265.e1-265.e12. doi: 10.1016/j.jtct.2025.02.003. Epub 2025 Feb 7.
9
Dual T cell depleted haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and anti-thymocyte globulin as a third salvage transplant for leukocyte adhesion deficiency with graft failure: a case report.
Front Immunol. 2025 Jan 8;15:1475448. doi: 10.3389/fimmu.2024.1475448. eCollection 2024.
10
Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency.
J Clin Immunol. 2025 Jan 6;45(1):65. doi: 10.1007/s10875-024-01850-2.
本文引用的文献
1
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
N Engl J Med. 2021 May 27;384(21):2002-2013. doi: 10.1056/NEJMoa2027675. Epub 2021 May 11.
2
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III.
Blood Adv. 2021 Jan 12;5(1):262-273. doi: 10.1182/bloodadvances.2020002185.
3
Is neutralization of IFN-γ sufficient to control inflammation in HLH?
Pediatr Blood Cancer. 2021 Mar;68(3):e28886. doi: 10.1002/pbc.28886. Epub 2021 Jan 6.
4
Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes.
J Clin Immunol. 2021 Feb;41(2):414-426. doi: 10.1007/s10875-020-00898-0. Epub 2020 Nov 6.
5
Cellular Therapies in Chronic Granulomatous Disease.
Front Pediatr. 2020 Jun 26;8:327. doi: 10.3389/fped.2020.00327. eCollection 2020.
6
Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults.
Blood. 2020 Sep 3;136(10):1201-1211. doi: 10.1182/blood.2020005590.
7
Clinical, Immunological, and Genetic Features in 49 Patients With ZAP-70 Deficiency: A Systematic Review.
Front Immunol. 2020 May 5;11:831. doi: 10.3389/fimmu.2020.00831. eCollection 2020.
8
Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis.
Blood Adv. 2020 May 12;4(9):1998-2010. doi: 10.1182/bloodadvances.2020001748.
9
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.
N Engl J Med. 2020 May 7;382(19):1811-1822. doi: 10.1056/NEJMoa1911326.
10
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Blood. 2020 Jun 4;135(23):2094-2105. doi: 10.1182/blood.2019002939.
Zotero 插件